Free Trial
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Lotus Pharmaceuticals logo
$0.0062 +0.00 (+6.90%)
As of 05/27/2025 03:16 PM Eastern

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Key Stats

Today's Range
$0.0062
$0.0062
50-Day Range
$0.0044
$0.0078
52-Week Range
$0.0006
$0.0079
Volume
20,000 shs
Average Volume
55,940 shs
Market Capitalization
$16.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

Receive LTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LTUS Stock News Headlines

Lotus Pharmaceuticals Inc Price / Book
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

LTUS Stock Analysis - Frequently Asked Questions

Lotus Pharmaceuticals' stock was trading at $0.0060 on January 1st, 2025. Since then, LTUS shares have increased by 3.3% and is now trading at $0.0062.
View the best growth stocks for 2025 here
.

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group Public (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LTUS
CIK
N/A
Employees
230
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,644,516,000
Free Float
N/A
Market Cap
$16.40 million
Optionable
Not Optionable
Beta
-2.57
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:LTUS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners